Introduction: Well-differentiated neuroendocrine tumors G3 (NETsG3) pts have a different biological behavior compared to those with neuroendocrine carcinomas (NECs). Sensitivity to platinum depends on Ki67 and there is no standard second line (2L). Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are predictive factors of cancer survival, but with limited evidence in NENs.
Aim(s): We investigated the clinical-pathological characteristics, biomarkers of systemic inflammation and therapeutic strategies in a series of NETsG3 and NECs.
Materials and methods: All pts with NETG3 and NEC diagnosed in our institution between 2011 and 2019 were reviewed. The baseline clinical-pathological characteristics, treatment schemes, inflammatory biomarkers and survival of all patients with at least one systemic treatment line were evaluated.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: MD Soledad Cameselle-Garcia
, Sardo E
, Landolfi S
, Merino-Casabiel X
, Sánchez J L
, Balsells J
, Pando E
, Blanco L
, Díez M
, Acosta D
, Capdevila J
, Hernando J
To read results and conclusion, please login ...
Further abstracts you may be interested in